Literature DB >> 8348925

Levels of anti-pneumococcal antibodies in young children in Papua New Guinea.

W S Pomat1, T A Smith, R C Sanders, C S Witt, J Montgomery, D Lehmann, M P Alpers.   

Abstract

Anti-pneumococcal polysaccharide antibody (anti-PPS) levels were measured in 153 serum samples collected from children aged between 2 and 47 months living in the highlands of Papua New Guinea (PNG). Fifty-seven of the samples were collected during acute episodes of lower respiratory tract infection (ALRI). Total IgA and IgG increased steadily with age; however, no association was found between the levels of these antibodies and the health status of the child. Total IgM levels showed little relationship to the age of the child but under 12 months of age levels were somewhat higher on average in children with pneumonia. For most of eight pneumococcal serotypes tested, specific IgG levels were found to decline rapidly in the first 6-8 months, reaching a minimum at approximately 12 months of age. Serotype 3 was exceptional in having very low titres in the youngest children. A separate analysis of 24 cord sera suggested that antibodies to this serotype do not usually cross the placenta in PNG. Children with pneumonia tended to have lower levels of specific IgG than healthy controls of the same age. Specific anti-PPS IgA levels were found to increase steadily with age, but were not associated with health status.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348925      PMCID: PMC2271208          DOI: 10.1017/s0950268800056739

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

2.  Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea.

Authors:  F Shann; M Gratten; S Germer; V Linnemann; D Hazlett; R Payne
Journal:  Lancet       Date:  1984-09-08       Impact factor: 79.321

Review 3.  Chemistry and immunochemistry of the pneumococcal polysaccharide vaccine with special reference to cross-reactions and immunologic factors.

Authors:  G Schiffman
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

4.  Serological diagnosis of pneumococcal disease with enzyme-linked immunosorbent assay (ELISA).

Authors:  E Berntsson; K A Broholm; B Kaijser
Journal:  Scand J Infect Dis       Date:  1978

5.  Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children.

Authors:  D Lehmann; T F Marshall; I D Riley; M P Alpers
Journal:  Ann Trop Paediatr       Date:  1991

6.  Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodies.

Authors:  D S Chudwin; D W Wara; G Schiffman; S G Artrip; A J Ammann
Journal:  Am J Dis Child       Date:  1985-04

7.  Antibody response to pneumococcal vaccination in children younger than five years of age.

Authors:  R M Douglas; J C Paton; S J Duncan; D J Hansman
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

8.  Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group.

Authors:  D W Teele; J O Klein; L Bratton; G R Fisch; O R Mathieu; P J Porter; S G Starobin; L D Tarlin; R P Younes
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

9.  Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines.

Authors:  S H Sell; P F Wright; W K Vaughn; J Thompson; G Schiffman
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

10.  IgG and IgM pneumococcal polysaccharide antibody responses in infants.

Authors:  D J Barrett; C G Lee; A J Ammann; E M Ayoub
Journal:  Pediatr Res       Date:  1984-11       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.